193 related articles for article (PubMed ID: 26691121)
21. Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing.
McGinty EE; Stuart EA; Caleb Alexander G; Barry CL; Bicket MC; Rutkow L
Implement Sci; 2018 Feb; 13(1):37. PubMed ID: 29482599
[TBL] [Abstract][Full Text] [Related]
22. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US.
Ballreich J; Mansour O; Hu E; Chingcuanco F; Pollack HA; Dowdy DW; Alexander GC
JAMA Netw Open; 2020 Nov; 3(11):e2023677. PubMed ID: 33146732
[TBL] [Abstract][Full Text] [Related]
23. Ethics, Public Health, and Addressing the Opioid Crisis.
Smith HJ
AMA J Ethics; 2020 Aug; 22(8):E647-650. PubMed ID: 32880350
[No Abstract] [Full Text] [Related]
24. Trends in Florida's Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use.
Delcher C; Wang Y; Young HW; Goldberger BA; Schmidt S; Reisfield GM
J Opioid Manag; 2017; 13(5):283-289. PubMed ID: 29199394
[TBL] [Abstract][Full Text] [Related]
25. The effect of state laws designed to prevent nonmedical prescription opioid use on overdose deaths and treatment.
Popovici I; Maclean JC; Hijazi B; Radakrishnan S
Health Econ; 2018 Feb; 27(2):294-305. PubMed ID: 28719096
[TBL] [Abstract][Full Text] [Related]
26. The effects of North Carolina's prescription drug monitoring program on the prescribing behaviors of the state's providers.
Ringwalt C; Garrettson M; Alexandridis A
J Prim Prev; 2015 Apr; 36(2):131-7. PubMed ID: 25466768
[TBL] [Abstract][Full Text] [Related]
27. Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States.
Chen Q; Larochelle MR; Weaver DT; Lietz AP; Mueller PP; Mercaldo S; Wakeman SE; Freedberg KA; Raphel TJ; Knudsen AB; Pandharipande PV; Chhatwal J
JAMA Netw Open; 2019 Feb; 2(2):e187621. PubMed ID: 30707224
[TBL] [Abstract][Full Text] [Related]
28. Opioid overdose deaths and potentially inappropriate opioid prescribing practices (PIP): A spatial epidemiological study.
Stopka TJ; Amaravadi H; Kaplan AR; Hoh R; Bernson D; Chui KKH; Land T; Walley AY; LaRochelle MR; Rose AJ
Int J Drug Policy; 2019 Jun; 68():37-45. PubMed ID: 30981166
[TBL] [Abstract][Full Text] [Related]
29. Compared with what? Estimating the effects of injury prevention policies using the synthetic control method.
Bonander C
Inj Prev; 2018 Jun; 24(Suppl 1):i60-i66. PubMed ID: 29127114
[TBL] [Abstract][Full Text] [Related]
30. Buprenorphine physician supply: Relationship with state-level prescription opioid mortality.
Knudsen HK; Havens JR; Lofwall MR; Studts JL; Walsh SL
Drug Alcohol Depend; 2017 Apr; 173 Suppl 1(Suppl 1):S55-S64. PubMed ID: 28363321
[TBL] [Abstract][Full Text] [Related]
31. Prescription Opioid Diversion Sources Among African Americans: Implications for Overdose Prevention.
Rigg KK
Subst Use Misuse; 2024; 59(8):1271-1274. PubMed ID: 38501692
[TBL] [Abstract][Full Text] [Related]
32. Exploration of the STOP Act and Opioid Deaths in North Carolina, 2010-2018.
Hughes P; Denslow S; Ostrach B; Fusco C; Tak C
Am J Public Health; 2020 Oct; 110(10):1573-1577. PubMed ID: 32816537
[No Abstract] [Full Text] [Related]
33. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study.
Park TW; Saitz R; Ganoczy D; Ilgen MA; Bohnert AS
BMJ; 2015 Jun; 350():h2698. PubMed ID: 26063215
[TBL] [Abstract][Full Text] [Related]
34. Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons.
Weisberg DF; Becker WC; Fiellin DA; Stannard C
Int J Drug Policy; 2014 Nov; 25(6):1124-30. PubMed ID: 25190034
[TBL] [Abstract][Full Text] [Related]
35. Impact of Florida's prescription drug monitoring program on drug- related fatal vehicle crashes: a difference-in-differences approach.
Tatar M; Jalali MS; Tak HJ; Chen LW; Araz OM; Wilson FA
Inj Prev; 2022 Apr; 28(2):105-109. PubMed ID: 34162702
[TBL] [Abstract][Full Text] [Related]
36. Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.
Rudd RA; Aleshire N; Zibbell JE; Gladden RM
MMWR Morb Mortal Wkly Rep; 2016 Jan; 64(50-51):1378-82. PubMed ID: 26720857
[TBL] [Abstract][Full Text] [Related]
37. State Legal Restrictions and Prescription-Opioid Use among Disabled Adults.
Meara E; Horwitz JR; Powell W; McClelland L; Zhou W; O'Malley AJ; Morden NE
N Engl J Med; 2016 Jul; 375(1):44-53. PubMed ID: 27332619
[TBL] [Abstract][Full Text] [Related]
38. Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov model.
Alexander GC; Ballreich J; Mansour O; Dowdy DW
Addiction; 2022 Apr; 117(4):969-976. PubMed ID: 34590369
[TBL] [Abstract][Full Text] [Related]
39. Opioid-overdose laws association with opioid use and overdose mortality.
McClellan C; Lambdin BH; Ali MM; Mutter R; Davis CS; Wheeler E; Pemberton M; Kral AH
Addict Behav; 2018 Nov; 86():90-95. PubMed ID: 29610001
[TBL] [Abstract][Full Text] [Related]
40. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
